CNS Stock Analysis: Buy, Sell, or Hold?

CNS - Cohen & Steers Inc.

INVESTMENT ADVICE
$61.69
-0.44 (-0.71%) ▼
5d: -0.4%
30d: -7.82%
90d: -1.74%
BUY
HIGH Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: Apr 15, 2026 12d

Get Alerted When CNS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: CNS shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$96.02
Based on 7.4% avg growth
INTRINSIC VALUE TODAY
$59.62
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.2x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: CNS is currently trading at $61.69, which is considered oversold relative to its 30-day fair value range of $61.91 to $66.32. The stock's valuation (Forward PE: 16.8) is in line with its historical norms (18.2). Remarkably, the market is currently pricing in an annual earnings decline of 2.6% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, CNS is showing sideways momentum. The price is currently testing key support at $60.17. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: CNS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (17th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $72.00 (+15.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position OVERSOLD
Fair Price Range $61.91 - $66.32
Company Quality Score 53/100 (HOLD)
Options IV Signal 17th percentile (COMPLACENCY WARNING)
Volume Confirmation HIGH
Confidence Score 90.4%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Options cheap (IV 17th percentile)
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($72.00)

Fair Price Analysis

30-Day Fair Range $61.91 - $66.32
Current vs Fair Value OVERSOLD
Expected Move (7 Days) ±$2.42 (3.9%)

Support & Resistance Levels

Support Level $60.17
Resistance Level $64.81
Current Trend Sideways
Technical data as of Apr 1, 2026

Fundamental Context

Forward P/E (Next Year Est.) 16.81
Wall Street Target $72.00 (+15.9%)
Revenue Growth (YoY) 2.9%
Earnings Growth (YoY) -24.5%
Profit Margin 27.6%
Valuation Discount vs History -2.6% cheaper
PE vs Historical 16.8 vs 18.2 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -2.6% (market-implied from PE analysis)
1-Year Target $60.51 (-3%)
2-Year Target $58.94 (-5%)
3-Year Target $57.41 (-8%)
3-Yr Target (if PE normalizes) (PE: 17→18) $62.17 (+0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.4, Growth: 10.8%) $112.35 (+81%)
Base: (SPY PE: 16.8, Growth: 10.8%) $84.49 (+36%)
Bear: (PE: 14.3, Growth: 10.8%) $71.81 (+16%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (21x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 20.94 | Current EPS (TTM): $2.97
Bull Case $85.13 (+34%)
Analyst growth 24.5%, PE expands to 23.0
Base Case $77.39 (+22%)
Market implied 24.5%, PE stable at 20.9
Bear Case $42.28 (-33%)
Severe decline -20.0%, PE contracts to 17.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.8 to 18.2
Stabilization Target: $67.28 (+8.3%)
PE Expansion Potential: +8.3%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: April 02, 2026 11:10 AM ET
Data refreshes hourly during market hours. Next update: 12:10 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
3
Buys
2
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Francis C Poli SELL 10000 shares 2026-02-12
Francis C Poli SELL 9696 shares 2026-02-11
Martin Cohen BUY 12708 shares 2025-11-20

Unlock Insider Activity

See real-time buying/selling by company executives for CNS.

Create Free Account

Already have an account? Log In

Top Rated Asset Management Stocks

Top-rated stocks in Asset Management by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
KKR
KKR & Co LP
STRONG BUY
21 analysts
$137 61 BUY
APO
Apollo Global Management…
STRONG BUY
19 analysts
$155 63 BUY
HASI
Hannon Armstrong Sustain…
STRONG BUY
16 analysts
$44 62 BUY
BX
Blackstone Group Inc
HOLD
23 analysts
$159 59 HOLD
OWL
Blue Owl Capital Inc
STRONG BUY
15 analysts
$15 58 HOLD

More Analysis for CNS

CNS Technical Chart CNS Price Prediction CNS Earnings Date CNS Investment Advisor CNS Fair Price Analyzer CNS Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals